Saxenda litigation — FAQ | DrugsMonitor.com

Frequently asked questions about Saxenda litigation, litigation status, eligibility, and how to request a confidential case review.

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes., FAQ, frequently asked questions